🥗 Nutrition & Supplements · 10 min read · Subtopic 4 of 5

Low-Carb vs Low-Fat, Finally

Thirty years of diet wars produced one genuinely useful answer, and it is boring: when adherence is equal, the diets work about equally, because adherence is the whole game. The head-to-head randomized trials — DIETFITS above all — are the scorecard this page reads slowly, so you can pick a diet without joining a tribe.

🔎 Evidence Snapshot ★★★★☆ Good — large, well-run RCTs agree; long-term and responder-phenotype questions remain

What the evidence supports

  • In DIETFITS (609 people), 12-month loss was 6.0 kg on low-carb versus 5.3 kg on low-fat — not a meaningful difference (JAMA, 2018).
  • Genotype-matched versus mismatched diets made no difference to weight loss in that trial — the "eat for your genes" prediction failed.
  • Across trials, the most consistent predictor of weight loss is adherence and retention, not macronutrient identity.

What remains uncertain

  • Whether insulin-secretion status predicts who responds better to low-carb — null in DIETFITS, hinted at in a small maintenance trial (BMJ, 2018) — is unresolved.
  • Long-term outcomes beyond two to three years are thin for both patterns.
  • "Low-carb" and "low-fat" are not one thing; quality of the chosen fats and carbs varies trial to trial and changes the result.

Evidence last reviewed: August 15, 2026. Conclusions may change as new research is published.

the war ends in a tie

6.0 vs 5.3 kg
Twelve-month weight loss, low-carb versus low-fat, in DIETFITS (JAMA, 2018)
4.7 · 4.4 · 2.9 kg
Two-year losses for low-carb, Mediterranean, and low-fat arms in DIRECT (NEJM, 2008)
−1.15 kg
Low-fat's average deficit versus higher-fat diets at 12 months, meta-analysis (Lancet Diabetes Endocrinol, 2015)

The Scorecard: What the Trials Actually Found

Mean Weight Loss Across the Head-to-Heads
Mean losses in the largest randomized comparisons. Within-trial differences were mostly not meaningful; the DIRECT low-fat arm is the visible outlier. Bars show group means, not what any individual experienced — within-arm variation was several times larger.
DIETFITS · low-carb, 12 months 6.0 kg DIETFITS · low-fat, 12 months 5.3 kg DIRECT · low-carb, 24 months 4.7 kg DIRECT · Mediterranean, 24 months 4.4 kg POUNDS LOST · all arms, 24 months ≈3.0 kg DIRECT · low-fat, 24 months 2.9 kg Sources: DIETFITS (JAMA, 2018); DIRECT (NEJM, 2008); POUNDS LOST (NEJM, 2009).

DIETFITS, Read Slowly

DIETFITS is the trial this debate had been waiting for: 609 overweight adults randomized to a healthy low-fat diet (around 20 g of fat to start) or a healthy low-carb diet (around 20 g of carbs to start), both coached toward whole foods, vegetables, and satiety — with no calorie targets, on purpose. At 12 months, low-carb lost 6.0 kg and low-fat 5.3 kg; the difference was not meaningful (JAMA, 2018). The trial also tested two popular claims directly: that DNA variants predict who thrives on which diet, and that insulin secretion does the same. Neither panned out — genotype-matched diets lost no more weight than mismatched ones, and baseline insulin secretion predicted nothing. The within-arm spread was the real story: some participants lost 30 kg, others gained, on both diets. When the same intervention produces that range, the question "which diet wins?" is asking about a few hundred grams of group mean while ignoring kilograms of individual variation.

One more detail matters for reading the null: the arms converged. By month twelve the low-carb group was eating around 130 g of carbohydrate a day and the low-fat group around 60 g of fat — both a long way from their starting extremes and, practically, not far from each other. When "low-carb" and "low-fat" both drift toward a whole-food middle, a null result is not evidence that diet composition is irrelevant; it is evidence that ordinary humans moderate extreme prescriptions into the same livable diet. The trials compare what people actually do with a label, not what the label promises.

Why Adherence Beats Identity

POUNDS LOST ran 811 people on four diets spanning 20% to 40% fat and 15% to 25% protein. At two years the arms had all lost about 3–4 kg — no meaningful differences — and the strongest predictor of success was attendance and self-reported adherence, not which diet had been assigned (NEJM, 2009). The pattern repeats across the trial literature: diets differ less in their biology than in their livability. Both low-carb and low-fat work in the studies mainly by simplifying choice — cutting a macro removes whole aisles of hyperpalatable food and, in practice, lowers energy intake. The environment design protocol explains why: the diet that survives is the one whose defaults you can live with, and that property belongs to the person, not the macro split.

Where Low-Carb Holds an Edge

Honest accounting gives low-carb a modest, consistent edge in the trials. DIRECT found the low-carb arm lost 4.7 kg versus 2.9 kg for low-fat at two years — the one meaningful difference in the big head-to-heads (NEJM, 2008). A randomized trial in obese adults found a very low-carb diet (under 40 g/day) beat low-fat for weight and several lipid markers over a year (Annals of Internal Medicine, 2014). And a meta-analysis of long-term trials found higher-fat, lower-carb approaches ahead of low-fat by about 1.15 kg at 12 months (Lancet Diabetes & Endocrinology, 2015). For insulin resistance and type 2 diabetes, carbohydrate restriction is a genuine clinical tool with trial support — the sugar topic owns that evidence. The edge is small, real, and partly mechanical: protein and fat are more satiating, so low-carb dieters often eat less without being told to.

Where Low-Fat Holds an Edge

The counter-evidence is also real. In a tightly controlled inpatient trial, adults offered an ad libitum plant-based low-fat diet ate roughly 700 kcal less per day than on an animal-based ketogenic diet, and lost more fat over two weeks (Nature Medicine, 2021) — a result that says something about the satiating power of bulky, low-calorie plants. Low-fat's broader problem is historical, not biological: the 1990s low-fat era replaced fat with refined carbohydrate, which the substitution evidence says is the one swap that buys nothing (see saturated fat, re-examined). Done well — legumes, whole grains, vegetables, lean protein — low-fat diets are simply a Mediterranean-adjacent pattern, and they perform like one. The diet wars made "low-fat" mean rice cakes and fat-free cookies; the trials that actually fed people real food tell a different story.

ClaimVerdict
Low-carb crushes low-fat for everyoneNot supported — head-to-head differences are small and usually not meaningful
DNA testing can pick your dietFailed in DIETFITS — genotype-matched diets lost no more weight
Adherence predicts weight lossStrong — the most consistent predictor across trials
Insulin secretion predicts low-carb responseUnresolved — null in DIETFITS; a small maintenance trial hints otherwise
Either diet can work when done with quality foodsSupported — both arms of the quality-focused trials lost weight
Low-fat diets are obsoleteNot supported — plant-based low-fat performs well in controlled settings

🤝 The war was always a marketing problem

Diet identity is not physiology. The trials find more variation within each diet arm than between the two diets, and the between-diet difference they do find is smaller than the between-person difference in adherence. Pick the pattern you can sustain, run it for a quarter, and let the quarterly audit score it — the label on the diet predicts less than your own calendar does.

Choosing Without a War

Questions, Answered Briefly

The Bottom Line

  1. The head-to-heads are a statistical tie: 6.0 versus 5.3 kg in DIETFITS is not a verdict, and most trials agree.
  2. Genotype matching failed its test; adherence is the predictor that keeps winning.
  3. Low-carb holds a small, real edge in several trials and a genuine clinical role in diabetes.
  4. Quality overrides identity: the fat you add to low-carb and the carbs you add to low-fat decide the health outcome.

Related Topics

Sources & further reading